| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 09/11/2009 | CA2716122A1 2-aminoquinolines |
| 09/11/2009 | CA2715842A1 2-aminoquinoline derivatives |
| 09/11/2009 | CA2715796A1 2-aryl and 2 -heteroaryl 4h-1-benzopyran-4-one-6-amidino derivatives for the treatment of arthritis, cancer and related pain |
| 09/11/2009 | CA2711247A1 2-aminoquinolines |
| 09/10/2009 | US20090227795 Target molecules of pladienolides, compounds binding to such target molecules, and screening method thereof |
| 09/10/2009 | US20090227636 substituted pyrrolidine derivatives, used for the treatment vision defects such as glaucoma or ocular hypertension |
| 09/10/2009 | US20090227635 Therapeutic compounds |
| 09/10/2009 | US20090227634 Pyrazole Derivatives as 5-LO-Inhibitors |
| 09/10/2009 | US20090227627 6-substituted-thio-2-amino-quinoline derivatives useful as inhibitors of beta-secretase (bace) |
| 09/10/2009 | US20090227592 Compounds effecting glucokinase |
| 09/10/2009 | US20090227581 such as 3-[3-(4-tert-Butyl-[1,2,3]triazol-1-yl)-1-(tetrahydro-pyran-4-yl)-propyl]-7-ethoxy-6-(2-fluoro-phenyl)-quinolin-2-ylamine, used in the treatment of Alzheimer's disease (AD), mild cognitive impairment, senility and/or dementia |
| 09/10/2009 | US20090227558 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/10/2009 | US20090227530 Sodium channel blockers |
| 09/10/2009 | US20090226411 Chemical derivatives and their application as antitelomerase agents |
| 09/09/2009 | EP2098512A1 Compounds and methods for treating dyslipidemia |
| 09/09/2009 | EP2098508A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 09/09/2009 | EP2097407A1 Pyrazole analogs |
| 09/09/2009 | EP2097405A2 Anti-viral compounds |
| 09/09/2009 | EP2097386A2 Substituted dihydroimidazoles and their use in the treatment of tumors |
| 09/09/2009 | EP2096921A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi, and compositions comprising them |
| 09/09/2009 | EP1893197B1 Chromane substituted benzimidazole derivatives as acid pump antagonists |
| 09/09/2009 | EP1670768B1 Compounds and methods for treating dyslipidemia |
| 09/09/2009 | EP1165096B1 Use of cytidine derivatives for the treatment of leukaemia |
| 09/09/2009 | CN101528728A 6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents |
| 09/09/2009 | CN100537565C 4-(aminomethyl)-piperidine benzamides as 5HT4 -antagonists |
| 09/09/2009 | CN100537556C Anomeric derivatives of monosaccharides |
| 09/09/2009 | CN100537538C Nove intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof |
| 09/09/2009 | CN100536841C Cyclopropyl and cyclobutyl epothilone analogs |
| 09/08/2009 | US7585986 Semi-synthesis of taxane intermediates and aziridine analogues and their conversion to paclitaxel and docetaxel |
| 09/08/2009 | US7585976 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting |
| 09/08/2009 | US7585888 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 09/08/2009 | US7585878 2-[(2,5-dimethylpyrrolidin-1-yl)methyl]-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)biphenyl-4-carboxamide; capsaicin receptor VR1 inhibitory activity; inflammatory pain and neurogenic pain, migraine, cluster headache, bladder diseases including overactive bladder |
| 09/08/2009 | US7585869 novel bicyclic derivatives that are useful in the treatment of abnormal cell growth, such as cancer; tyrosine kinase inhibitors |
| 09/08/2009 | US7585853 Compounds having selective inhibiting effect at GSK3 |
| 09/08/2009 | CA2546894C Reference standard for characterization of rosuvastatin |
| 09/08/2009 | CA2387351C Indole derivatives as tyrosine kinase inhibitors |
| 09/08/2009 | CA2342739C Azetidine derivatives, preparation and medicines containing them |
| 09/08/2009 | CA2316388C Tetrahydrobenzindole derivative |
| 09/08/2009 | CA2295090C 2,4,4-trisubstituted-1,3-dioxolane antifungals |
| 09/08/2009 | CA2293714C Benzpyrido cycloheptane compounds useful for inhibition of farnesyl protein transferase |
| 09/08/2009 | CA2287558C Heterocyclic derivatives and their use as antithrombotic agents |
| 09/08/2009 | CA2213466C Inhibitors of microsomal triglyceride transfer protein and method |
| 09/03/2009 | WO2009107764A1 Composition for agricultural use for controlling or preventing plant diseases caused by plant pathogens |
| 09/03/2009 | WO2009107391A1 Compound having 6-membered aromatic ring |
| 09/03/2009 | WO2009107387A1 2-oxochromene derivative |
| 09/03/2009 | WO2009106982A1 Indazole derivatives |
| 09/03/2009 | WO2009106817A2 Compound |
| 09/03/2009 | WO2009106599A2 Substituted piperidines as therapeutic compounds |
| 09/03/2009 | WO2009106471A2 New angiotensin ii receptor blocker derivatives |
| 09/03/2009 | WO2009105824A1 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor |
| 09/03/2009 | WO2009105823A1 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
| 09/03/2009 | US20090221839 Preparation of an Atorvastatin Intermediate |
| 09/03/2009 | US20090221824 Enantioselective process |
| 09/03/2009 | US20090221699 Fab I Inhibitors |
| 09/03/2009 | US20090221666 Stilbene derivatives and methods of inhibiting cancer cell growth and microbial growth |
| 09/03/2009 | US20090221663 Pyrazole derivatives as 11-beta-hsd1 inhibitors |
| 09/03/2009 | US20090221661 Phosphodiesterase 4 inhibitors |
| 09/03/2009 | US20090221644 Gpcr Agonists |
| 09/03/2009 | US20090221643 4-phenyl-3-(2-propylsulfonylamino) tetrahydrofuran derivatives which potentiate glutamate receptors and are useful in the treatment of schizophrenia |
| 09/03/2009 | US20090221597 Heteroaryl derivatives as cftr modulators |
| 09/03/2009 | US20090221575 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 09/03/2009 | US20090221424 Pesticides |
| 09/03/2009 | US20090220662 Isosorbide derivatives and their use as flavor modifiers, tastants, and taste enhancers |
| 09/03/2009 | US20090220454 Use of the histone deacetylase inhibitor N-hydroxy-4-[2-(3-dimethylaminobenzofuran-2-ylcarbonylamino)ethoxy]benzamide (aka CRA-24781, PCI-24781) for treating myelogenous leukemia (MML) or acute myelogenous leukemia (AML), optionally in combination therapy |
| 09/03/2009 | US20090219526 Reagents for biomolecular labeling, detection and quantification employing raman spectroscopy |
| 09/03/2009 | CA2716898A1 Compound having 6-membered aromatic ring |
| 09/03/2009 | CA2716647A1 Composition for agricultural use for controlling or preventing plant diseases caused by plant pathogens |
| 09/03/2009 | CA2716316A1 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor |
| 09/03/2009 | CA2716250A1 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
| 09/03/2009 | CA2714607A1 Hexahydrocyclopentyl[f]indazole carboxamides and derivatives thereof as selective glucocorticoid receptor modulators |
| 09/03/2009 | CA2714573A1 Indazole derivatives |
| 09/03/2009 | CA2714058A1 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease |
| 09/03/2009 | CA2712695A1 New angiotensin ii receptor blocker derivatives |
| 09/02/2009 | EP2096108A1 Novel organic electroluminescent compounds and organic electroluminscent device using the same |
| 09/02/2009 | EP2096104A1 Organic diamines as mGluR7 modulators |
| 09/02/2009 | EP2094689A2 Indolylmaleimide derivatives as kinase inhibitors |
| 09/02/2009 | EP2094683A2 Bicyclic compounds and use as antidiabetics |
| 09/02/2009 | EP2094680A2 Imidazoles as aldosterone synthase inhibitors |
| 09/02/2009 | EP2094670A1 Heterocyclyc sulfonamides having edg-i antagonistic activity |
| 09/02/2009 | EP2094669A2 1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors |
| 09/02/2009 | EP2094656A2 P<0}{0pyrrol derivatives, preparation and use of the same in therapy<0} |
| 09/02/2009 | EP1937672B1 N-[(4,5-diphenylpyrimidin-2-yl)methyl]amine derivatives, the preparation thereof and their therapeutic use |
| 09/02/2009 | EP1909792B1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
| 09/02/2009 | EP1899322B1 Isoquinoline derivatives as inhibitors of rho-kinase |
| 09/02/2009 | EP1572215B1 Benzo[d]azepine derivatives for the treatment of neurological disorders |
| 09/02/2009 | EP1470137B1 Edg receptor agonists |
| 09/02/2009 | EP1458392B1 Acridones as inhibitors of impdh enzyme |
| 09/02/2009 | EP1282617B1 Hydantoin derivatives with affinity for somatostatin receptors |
| 09/02/2009 | CN101522668A Oxyindole derivatives as 5ht4 receptor agonists |
| 09/02/2009 | CN101522667A Novel crystalline modification of 4- (N-methyl-2-chloro-5-pyridylmethylamino) -2,5-dihydrofuran-2-one |
| 09/02/2009 | CN101522666A Nucleosides for suppressing or reducing the development of resistance in cytostatic therapy |
| 09/02/2009 | CN101522665A Oxepin derivative |
| 09/02/2009 | CN101519386A Large conductance calcium-activated K channel opener |
| 09/02/2009 | CN101519375A Antifungal pyrazoline-substituting compound and preparation method and application thereof |
| 09/02/2009 | CN100534991C Heterocyclic inhibitors of ERK 2 and uses thereof |
| 09/02/2009 | CN100534990C Pyrrolidone carboxamides |
| 09/02/2009 | CN100534983C Cyclic amine derivatives, processes for their preparation, and pharmaceutical compositions containing them |
| 09/01/2009 | US7582781 epoxidation to produce 1,2-Epoxy-2-(2,4-difluorophenyl)butan-3-ol intermediate for pharmaceutical drugs, a triazole antifungal agent |
| 09/01/2009 | US7582770 3-(2-{1-[(3-Cyclopentyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carbonyl)amino]cyclobutyl}-1-methyl-1H-benzoimidazol-5-yl)acrylic acid; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 09/01/2009 | US7582767 N-[7-(4-piperidinyl)oxy-1-benzofuran-5-yl]-5-hydroxymethyl-2-methoxybenzenesulfonamide; the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes, CNS disorders, to achieve reduction of body weight and/or body weight gain |